《胸部肿瘤学杂志》20周年系列:胸外科二十年进展
本文回顾《Journal of Thoracic Oncology》创刊20年来胸外科在肺癌、胸膜间皮瘤及胸腺上皮肿瘤领域的演变,重点涉及TNM分期多次修订(含第9版)、完全切除的预后价值、≤2 cm病灶的亚肺叶切除替代肺叶切除,以及视频/机器人辅助微创手术在不影响肿瘤学结局下的临床获益。
要点
- 肺癌、胸膜间皮瘤及胸腺上皮肿瘤的TNM分期20年间多次修订,第9版由IASLC分期与预后因素组基于全球生存数据验证。
- 完全切除仍是肺癌被低估的重要预后因素,当前关注局部晚期肺癌多学科治疗中的技术可切除性。
- 对≤2 cm病灶,肺段切除与宽楔形切除等亚肺叶切除在特定亚组中已被证实可替代肺叶切除。
核心结论
- 胸外科在肺癌多学科治疗中的地位已牢固确立,微创技术在不影响肿瘤学结局下带来明确临床获益。
研究设计与样本
- 本文为《Journal of Thoracic Oncology》20周年系列综述,总结近20年胸部肿瘤外科诊疗变化。
主要发现
- 肺癌、胸膜间皮瘤和胸腺上皮肿瘤的TNM分期在20年间经历多次修订,第9版由IASLC分期与预后因素组分析全球生存数据并验证。
- 完全切除是肺癌被低估的重要预后因素,当前关注局部晚期肺癌多学科治疗中的技术可切除性。
- 对≤2 cm病灶,包括肺段切除和宽楔形切除的亚肺叶切除在特定亚组中被证明可替代肺叶切除。
- 视频辅助或机器人辅助胸外科手术带来明确临床获益且不损害肿瘤学结局。
- 手术与新辅助、辅助及围手术期治疗的整合正在进一步评估以确定最佳治疗策略。
临床怎么用
- 对≤2 cm的特定亚组肺癌病灶,可考虑肺段切除或宽楔形切除等亚肺叶切除替代肺叶切除。
- 早期肺癌可优先考虑视频辅助或机器人辅助微创手术,以在不影响肿瘤学结局下获得临床获益。
- 局部晚期肺癌应重视完全切除这一预后因素,并在多学科治疗框架下评估技术可切除性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the last 20 years, major changes have occurred in the diagnosis and management of thoracic oncologic pathology. Furthermore, thoracic surgery has undergone considerable changes since the inception of the Journal of Thoracic Oncology in 2006. Regarding staging of lung cancer, pleural mesothelioma, and thymic epithelial tumors, several revisions were implemented in the TNM classification. The recently published ninth edition represents a tremendous effort of the Staging and Prognostic Factors Group of the International Association for the Study of Lung Cancer to analyze worldwide survival data and to validate the proposed changes in newly designed categories. Complete resection of a lung cancer remains an underestimated but important prognostic factor, and current attention is directed to technical resectability within multimodality therapy for locoregional advanced lung cancer. Integration of surgery within protocols of neoadjuvant, adjuvant, and perioperative therapies is further evaluated to determine the optimal therapeutic strategy. For smaller lesions less than or equal to 2 cm, sublobar resection, comprising segmentectomy and wide wedge excision, has been proven to be an alternative to lobectomy in specific subgroups. In the last 20 years, minimally invasive techniques have been introduced to provide new approaches to the thoracic cavity, especially for early stage lung cancer. Interventions performed by video- or robotic-assisted thoracic surgery are associated with a clear clinical benefit without compromising oncologic outcome. The role of thoracic surgery for resectable lung cancer cases has been firmly established, and surgery has become an integral part of multimodality therapy, but undoubtedly, further refinements will be made in the forthcoming 20 years!
引用
- Agrafiotis AC, Rami-Porta R, Altorki N, et al. Journal of Thoracic Oncology 20th Anniversary Series Surgery. J Thorac Oncol. 2026. PMID: 41483000. doi:10.1016/j.jtho.2025.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。